We have placed cookies on your computer to help make this website better. We use a Matomo Analytics script which sets performance cookies. More details and information can be found in our cookie policy. Please refer to the privacy statement to adjust your settings for the website analytics tracking by Matomo (e.g. deny use/opt-out).

I'm ok with this

Initiatives | About us| Grünenthal Pharma Ltd. Ireland

The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 32 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 5,200 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

Innovation is at the heart of everything that we do. It’s the driving force behind new ideas and future therapies.

... Research & Development

For us, innovation goes beyond drug development. Our innovation is built on expert knowledge of disease-pathophysiology’s, understanding of the patient, the use of big data and state-of-the-art technologies such as devices that result in innovative solutions for the patients need.

... Strategy

Our R&D pipeline is a source of great excitement – we currently have several new drug candidates and technologies in different phases of development.

... Pipeline

Our key innovation area is pain.

... Focus area

Collaboration with the scientific community is central to our R&D strategy. Let’s work together – collaborate with us!

... Collaborate with us

Taking action against pain

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

CHANGE PAIN®

CHANGE PAIN® aims to understand the needs of pain patients and develops solutions to improve the management of pain. Since the initiative was launched in twelve European countries in 2009, CHANGE PAIN® already has a history of success in chronic pain management. Many tools have been developed to make physicians’ daily practice easier and more than 65,000 healthcare professionals have been involved in CHANGE PAIN® educational activities, either completing web-based learning modules or attending workshops across Europe.

... Check out the latest eCME modules

EFIC-Grünenthal Grant (E-G-G)

We have been working with the European Pain Federation EFIC® since 2004 to support pain scientists in developing a better understanding of chronic pain and providing relief to patients that are suffering.

... Check out the latest E-G-G research projects

“My pain feels like”

We believe that it is important that patients can express and describe their symptoms in detail to support early diagnosis and effective treatment. This key insight has inspired us to develop the “My pain feels like…” initiative which is focused on enabling communication between patients and physicians.

... Get to know “My pain feels like”

Societal Impact of Pain (SIP)

This international platform was created in 2010 as a joint initiative between Grünenthal and the European Pain Federation EFIC®. Its objective is to raise awareness around the impact of pain on our societies, health and economic systems.

... Read more about SIP

Supporting patients with our products

Our ambition is to deliver five new products by 2022. If you are a healthcare professional, find out what we have already achieved so far by exploring our therapeutic range and visit the Grünenthal Health website.

... Grünenthal Health website